CAS: 1672662-14-4
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | PT2399 REF: TM-T12675LCAS: 1672662-14-4 | 98.8% - 99.07% | 96.00 €~1,290.00 € | Tue 07 Jan 25 |
 | PT2399 REF: 4Z-K-031005CAS: 1672662-14-4 | - - - | To inquire | Mon 13 Jan 25 |
 | PT2399 REF: 3D-XRC66214CAS: 1672662-14-4 | Min. 95% | To inquire | Tue 18 Feb 25 |
PT2399
CAS:1672662-14-4
PT2399, an oral HIF-2 inhibitor, blocks HIF-2α/1β dimerization, showing strong in vivo antitumor effects.
Formula:
C17H10F5NO4S
Purity:
98.8% - 99.07%
Color and Shape:
Solid
Molecular weight:
419.32
Ref: TM-T12675L
| 1mg | 96.00 € | ||
| 5mg | 230.00 € | ||
| 10mg | 346.00 € | ||
| 25mg | 625.00 € | ||
| 50mg | 922.00 € | ||
| 100mg | 1,290.00 € | ||
| 1mL*10mM (DMSO) | 253.00 € |
Estimated delivery in United States, on Tuesday 7 Jan 2025
Ref: 4Z-K-031005
| 10mg | To inquire | ||
| 25mg | To inquire | ||
| 50mg | To inquire | ||
| 100mg | To inquire |
Estimated delivery in United States, on Monday 13 Jan 2025
PT2399
CAS:1672662-14-4
PT2399 is a molecule that is structurally related to the fatty acid ursolic acid. It …
Formula:
C17H10F5NO4S
Purity:
Min. 95%
Molecular weight:
419.3 g/mol
Ref: 3D-XRC66214
| 10mg | To inquire | ||
| 25mg | To inquire | ||
| 50mg | To inquire |
Estimated delivery in United States, on Tuesday 18 Feb 2025
